Overview
Muhammad Shurafa is a Hematologist in Grosse Pointe Woods, Michigan. Dr. Shurafa is rated as an Experienced provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Polycythemia Vera, Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and RUNX1 Familial Platelet Disorder.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
Regents Of The University Of Michigan
Erica Campagnaro is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Campagnaro is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). Her top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Campagnaro is currently accepting new patients.
Ascension St John Hospital
Daniel Lebovic is a Hematologist Oncology specialist and an Oncologist in Grosse Pointe Woods, Michigan. Dr. Lebovic is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Monoclonal Gammopathy of Undetermined Significance (MGUS), Polycythemia Vera, Schnitzler Syndrome, Bone Marrow Aspiration, and Endoscopy. Dr. Lebovic is currently accepting new patients.
Regents Of The University Of Michigan
Matthew Pianko is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Pianko is rated as a Distinguished provider by MediFind in the treatment of Monoclonal Gammopathy of Undetermined Significance (MGUS). His top areas of expertise are Multiple Myeloma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma, and Bone Marrow Transplant. Dr. Pianko is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Polycythemia VeraDr. Shurafa isDistinguished. Learn about Polycythemia Vera.
- Advanced
- Chronic Myelogenous Leukemia (CML)Dr. Shurafa isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Philadelphia-Negative Chronic Myeloid Leukemia
- RUNX1 Familial Platelet DisorderDr. Shurafa isAdvanced. Learn about RUNX1 Familial Platelet Disorder.
- Experienced
- Acute Myelomonocytic LeukemiaDr. Shurafa isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult Immune ThrombocytopeniaDr. Shurafa isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnemiaDr. Shurafa isExperienced. Learn about Anemia.
- Autoimmune Hemolytic AnemiaDr. Shurafa isExperienced. Learn about Autoimmune Hemolytic Anemia.
- Blood ClotsDr. Shurafa isExperienced. Learn about Blood Clots.
- Childhood Acute Myeloid LeukemiaDr. Shurafa isExperienced. Learn about Childhood Acute Myeloid Leukemia.